Session » Vasculitis I: Novel Approaches to Therapy
- 2:30PM-4:00PM
-
Abstract Number: 978
A Randomized Clinical Trial of CCX168, an Orally Administered C5aR Inhibitor for Treatment of Patients with ANCA-Associated Vasculitis
- 2:30PM-4:00PM
-
Abstract Number: 979
A Randomized Double-Blind Trial of Abatacept and Glucocorticoids for the Treatment of Takayasu’s Arteritis
- 2:30PM-4:00PM
-
Abstract Number: 976
Efficacy and Safety of Tocilizumab in Patients with Refractory Takayasu Arteritis: Results from a Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial in Japan
- 2:30PM-4:00PM
-
Abstract Number: 975
Maintenance Therapy Improves Long-Term Outcomes in Patients with Primary Angiitis of the Central Nervous System
- 2:30PM-4:00PM
-
Abstract Number: 980
Short-Course Glucocorticoids in ANCA-Associated Vasculitis: A Proof of Concept Study